Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001209191-24-000782 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-04 | 2024-01-02 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | S - Sale+OE | $63.93 | -1,667 | 21.6K | -7% | -$106.6K |
| D | 2024-01-04 | 2024-01-02 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | M - OptEx | $21.41 | +1,667 | 22.4K | +8% | +$35.7K |
| D | 2024-01-04 | 2024-01-02 | PCVX | Eydelman Mikhail | SVP, Gen Counsel, Corp Sec | M - OptEx | $0.00 | +1,667 | 193.3K | +0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | S | D | 928 | $64.31 | 20,710 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $64.13 to $65.12. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-01-02 | M | A | 1,667 | $21.41 | 22,377 | D | — | — | |
| 3 | Common | Common Stock | 2024-01-02 | S | D | 141 | $62.91 | 22,236 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $62.01 to $62.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-01-02 | S | D | 598 | $63.59 | 21,638 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $63.13 to $64.00. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2024-01-02 | M | A | 1,667 | $0.00 | 193,333 | D | $21.41 · — to 2032-05-08 | 1,667 Common Stock | (F5) 1/4 of the shares subject to the option shall vest on April 1, 2023, and 1/48 of the shares shall vest monthly thereafter, subject to Reporting Person's continuous service to the Company through each such date. |